{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:10:04Z","timestamp":1789560604553,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100764","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:35:03Z","timestamp":1784046903000},"page":"100764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing antifungal drugs for Oral squamous cell carcinoma using network pharmacology, molecular docking and molecular dynamics approaches"],"prefix":"10.1016","volume":"24","author":[{"given":"Anju","family":"Mayadevi Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bounika Esvanth","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhi Venkatshree","family":"Anand Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish Srinivas","family":"Kondaveeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnanasambandam","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Ramshankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyambika","family":"Catakapatri Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgeb.2026.100764_bb0005","doi-asserted-by":"crossref","unstructured":"Francis DL, Pape Reddy SS. Oral cancer disparities in low- and middle-income countries: a Global Health equity perspective on prevention, early detection, and treatment access. Ann Glob Health 2025;91(1):81. doi:https:\/\/doi.org\/10.5334\/aogh.5003. PMID: 41321703; PMCID: PMC12662160.","DOI":"10.5334\/aogh.5003"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100764_bb0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-025-06098-w","article-title":"The global, regional, and national burden of oral cancer, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"151","author":"Wu","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jgeb.2026.100764_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.jgeb.2026.100764_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761379","article-title":"The molecular basis and therapeutic aspects of cisplatin resistance in Oral squamous cell carcinoma","volume":"11","author":"Cheng","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jgeb.2026.100764_bb0025","doi-asserted-by":"crossref","unstructured":"Baker NC, Ekins S, Williams AJ, Tropsha A. A bibliometric review of drug repurposing. Drug Discov Today 2018 23(3):661\u2013672. doi:https:\/\/doi.org\/10.1016\/j.drudis.2018.01.018. Epub 2018 Jan 9. PMID: 29330123; PMCID: PMC5963941.","DOI":"10.1016\/j.drudis.2018.01.018"},{"issue":"8","key":"10.1016\/j.jgeb.2026.100764_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081463","article-title":"Revitalizing cancer treatment: exploring the role of drug repurposing","volume":"16","author":"Malla","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100764_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.jgeb.2026.100764_bb0040","series-title":"Pharmaceutical Science","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1006501","article-title":"Repurposed Drugs: Current Trends in Drug Discovery","author":"Srikanth","year":"2024"},{"key":"10.1016\/j.jgeb.2026.100764_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jare.2022.08.018","article-title":"Repurposing antifungal drugs for cancer therapy","volume":"48","author":"Weng","year":"2023","journal-title":"J Adv Res"},{"issue":"9\u201310","key":"10.1016\/j.jgeb.2026.100764_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1439-0507.1998.tb00364.x","article-title":"Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy","volume":"41","author":"M\u00fccke","year":"1998","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100764_bb0055","first-page":"511","article-title":"High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study","volume":"12","author":"Torres","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgeb.2026.100764_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1410942","article-title":"Network pharmacology: an efficient but underutilized approach in oral, head and neck cancer therapy-a review","volume":"15","author":"Muthuramalingam","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/07391102.2024.2425831","article-title":"Targeting mitochondrial dynamics: an in-silico approach for repurposing antifungal drugs in OSCC treatment","volume":"44","author":"Raali","year":"2026","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jgeb.2026.100764_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1302059","article-title":"Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma","volume":"14","author":"Hao","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgeb.2026.100764_bb0075","article-title":"Repurposing antifungal drugs for oral cancer treatment: mechanistic insights and clinical potential\u2014a narrative review","author":"Nair","year":"2026","journal-title":"J Int Soc Prev Community Dent"},{"key":"10.1016\/j.jgeb.2026.100764_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.563838","article-title":"Inhibition of CAL27 oral squamous carcinoma cell by targeting hedgehog pathway with Vismodegib or Itraconazole","volume":"10","author":"Freitas","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jgeb.2026.100764_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117695","article-title":"Anti-fungal drug itraconazole exerts anti-cancer effects in oral squamous cell carcinoma via suppressing hedgehog pathway","volume":"254","author":"Ban","year":"2020","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100764_bb0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mc.20800","article-title":"Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis","volume":"51","author":"Chien","year":"2012","journal-title":"Mol Carcinog"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100764_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4149\/neo_2013_052","article-title":"Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in oral squamous cell carcinoma cells","volume":"60","author":"Li","year":"2013","journal-title":"Neoplasma"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100764_bb0100","article-title":"The in vitro and in vivo antitumor effects of Clotrimazole on Oral squamous cell carcinoma","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.jgeb.2026.100764_bb0105","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2174\/1568026620666200128143230","article-title":"Recent development of 1,2,4-triazole-containing compounds as anticancer agents","volume":"20","author":"Wen","year":"2020","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100764_bb0110","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/cas.14432","article-title":"Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressor","volume":"111","author":"Yoon","year":"2020","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89655-w","article-title":"Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma","volume":"11","author":"Greenberg","year":"2021","journal-title":"Sci Rep"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100764_bb0120","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.jgeb.2026.100764_bb0125","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgeb.2026.100764_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100764_bb0135","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100764_bb0140","doi-asserted-by":"crossref","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","article-title":"OMIM.org: leveraging knowledge across phenotype-gene relationships","volume":"47","author":"Amberger","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100764_bb0150","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100764_bb0155","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"suppl 4","key":"10.1016\/j.jgeb.2026.100764_bb0160","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"W1","key":"10.1016\/j.jgeb.2026.100764_bb0165","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100764_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jgeb.2026.100764_bb0175","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.jgeb.2026.100764_bb0180","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"13","key":"10.1016\/j.jgeb.2026.100764_bb0185","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1080\/07391102.2019.1667265","article-title":"Structural insights of metallo-beta-lactamase revealed an effective way of inhibition of enzyme by natural inhibitors","volume":"38","author":"Gangadharappa","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100764_bb0190","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"Open source drug discovery consortium; Lynn A. g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jgeb.2026.100764_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0959-8049(01)00233-7","article-title":"The EGFR as a target for anticancer therapy\u2014focus on cetuximab","volume":"37","author":"Baselga","year":"2001","journal-title":"Eur J Cancer"},{"issue":"suppl 6","key":"10.1016\/j.jgeb.2026.100764_bb0200","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdm222","article-title":"Erlotinib in cancer treatment","volume":"18","author":"Bareschino","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030819","article-title":"Structural insight and development of EGFR tyrosine kinase inhibitors","volume":"27","author":"Amelia","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jgeb.2026.100764_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.857430","article-title":"Identification of zinc-binding inhibitors of matrix metalloproteinase-9 to prevent cancer through deep learning and molecular dynamics simulation approach","volume":"9","author":"Mathpal","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100764_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100764_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17111425","article-title":"Matrix Metalloproteinase-9 (MMP-9) as a therapeutic target: insights into molecular pathways and clinical applications","volume":"17","author":"Wolosowicz","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.102.039651","article-title":"Novel small molecule inhibitors of Caspase-3 block cellular and biochemical features of apoptosis","volume":"304","author":"Scott","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jgeb.2026.100764_bb0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.21516","article-title":"Selective targeting of antiapoptotic BCL-2 proteins in cancer","volume":"39","author":"Timucin","year":"2019","journal-title":"Med Res Rev"},{"issue":"36","key":"10.1016\/j.jgeb.2026.100764_bb0235","doi-asserted-by":"crossref","first-page":"41040","DOI":"10.1021\/acsomega.5c03481","article-title":"Identification of tripeptide inhibitors targeting MAPK3 in Leishmania martiniquensis and Leishmania orientalis using molecular modeling, virtual screening, molecular dynamics, and in vitro approach","volume":"10","author":"Kiriwan","year":"2025","journal-title":"ACS Omega"},{"issue":"27","key":"10.1016\/j.jgeb.2026.100764_bb0240","doi-asserted-by":"crossref","first-page":"16799","DOI":"10.1039\/D2CP01780F","article-title":"Molecular investigation of the dual inhibition mechanism for targeted P53 regulator MDM2\/MDMX inhibitors","volume":"24","author":"Zhao","year":"2022","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.jgeb.2026.100764_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109053","article-title":"Small-molecule inhibitors of GSK3\u03b2: therapeutic potential and structure-activity relationship in multiple systems","volume":"165","author":"Wang","year":"2025","journal-title":"Bioorg Chem"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100764_bb0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/0113892002312369240703102215","article-title":"Role of cytochrome P450 3A4 in Cancer drug resistance: challenges and opportunities","volume":"25","author":"Pandey","year":"2024","journal-title":"Curr Drug Metab"},{"issue":"8","key":"10.1016\/j.jgeb.2026.100764_bb0255","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hed.27697","article-title":"Monoamine oxidase B inhibits epithelial-mesenchymal transition and trigger apoptosis via targeting ERK1\/2 signaling pathway in head and neck squamous cell carcinoma","volume":"46","author":"Qi","year":"2024","journal-title":"Head Neck"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100764_bb0260","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The gene ontology resource: enriching a GOld mine","volume":"49","author":"The Gene Ontology Consortium","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.jgeb.2026.100764_bb0265","doi-asserted-by":"crossref","first-page":"D587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0270","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0275","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4\u20135","key":"10.1016\/j.jgeb.2026.100764_bb0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"Warnakulasuriya","year":"2009","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100764_bb0285","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/j.0022-0337.2001.65.4.tb03403.x","article-title":"Tobacco use and oral cancer: a global perspective","volume":"65","author":"Johnson","year":"2001","journal-title":"J Dent Educ"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100764_bb0290","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0295","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.oraloncology.2005.07.009","article-title":"Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?","volume":"42","author":"Brouwer","year":"2006","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100764_bb0305","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100764_bb0320","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100764_bb0325","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/jomfp.jomfp_149_22","article-title":"Assessment of epidermal growth factor receptor in histological, clinical and pathological staging of oral squamous cell carcinoma","volume":"26","author":"Umarani","year":"2022","journal-title":"J Oral Maxillofac Pathol"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/njms.NJMS_279_20","article-title":"Evaluation of matrix metalloproteinase 9 gene expression in oral squamous cell carcinoma and its clinicopathological correlation","volume":"12","author":"Umashankar","year":"2021","journal-title":"Natl J Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100764_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-018-0035-4","article-title":"The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer","volume":"24","author":"Mandel","year":"2018","journal-title":"Mol Med"},{"issue":"37","key":"10.1016\/j.jgeb.2026.100764_bb0345","doi-asserted-by":"crossref","first-page":"62759","DOI":"10.18632\/oncotarget.18663","article-title":"Interplay between apoptosis and autophagy in colorectal cancer","volume":"8","author":"Qian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jgeb.2026.100764_bb0350","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00044-024-03360-7","article-title":"CYP3A4 drug metabolism considerations in pediatric pharmacotherapy","volume":"33","author":"Vander Schaaf","year":"2024","journal-title":"Med Chem Res"},{"issue":"24","key":"10.1016\/j.jgeb.2026.100764_bb0355","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1021\/acs.jmedchem.8b01252","article-title":"Novel tetrazole-containing analogues of Itraconazole as potent antiangiogenic agents with reduced cytochrome P450 3A4 inhibition","volume":"61","author":"Bauer","year":"2018","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100764_bb0360","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4062\/biomolther.2018.042","article-title":"Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast Cancer cells","volume":"26","author":"Bae","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100764_bb0365","first-page":"1250","article-title":"Identification of potential inhibitors against MMP-9 from natural sources using structure-based virtual screening and MD simulations","volume":"42","author":"Raha","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jgeb.2026.100764_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107639","article-title":"Molecular dynamics, MM\/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening","volume":"99","author":"Ornnork","year":"2020","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.jgeb.2026.100764_bb0375","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1038\/s41598-024-64781-3","article-title":"Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression","volume":"14","author":"Chauhan","year":"2024","journal-title":"Sci Rep"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:48:48Z","timestamp":1789559328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26001083"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100764","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing antifungal drugs for Oral squamous cell carcinoma using network pharmacology, molecular docking and molecular dynamics approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100764"}}